Why is Medicamen Biotec falling/rising?

As of 05-Sep, Medicamen Biotech Ltd's stock is currently priced at Rs. 352.00, reflecting an increase of Rs. 5.7, or 1.65%. The stock has shown a performance today that outperformed its sector by 1.72%, and there has been a notable rise in investor participation, with delivery volume increasing by 17.7% compared to the 5-day average. However, despite today's positive movement, the stock has experienced a significant decline over the longer term, with a year-to-date drop of 30.88% and a 3-year decline of 67.74%. The stock is currently above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed momentum in the context of its recent performance.
In the broader market context, Medicamen Biotech's short-term return of 2.41% over the past week has outpaced the Sensex, which has only increased by 1.13% during the same period. However, the stock's longer-term performance contrasts sharply with the benchmark, as it has underperformed significantly over the past month and year. The overall market sentiment appears to be more favorable, as indicated by the Sensex's positive return of 3.29% year-to-date, while Medicamen Biotech continues to struggle with substantial losses. This divergence suggests that while there may be short-term optimism reflected in today's price movement, the company faces ongoing challenges that have impacted its performance over a longer horizon.